Orem, Utah

We conduct high quality psychiatric clinical trials with a specialty in psychedelic medicines.

Questions? Call or text 801-871-5516

Now enrolling in Orem, Utah

See all studies

Depression

Ascend Study

We are doing research for a new investigational treatment option to see if it is effective in improving depression. If you suffer from depression, you may be eligible to participate.

PTSD

EMPOWER Study

The EMPOWER Study is a clinical trial exploring a new oral investigational medication for people experiencing symptoms of post-traumatic stress disorder (PTSD).

Anxiety

RECLAIM Study

This research study is evaluating a single dose of an investigational psychedelic medication vs. placebo to see if it may help reduce symptoms of generalized anxiety disorder (GAD).

Bipolar

Illuminate1 Study

The Illuminate1 Study is evaluating the safety and efficacy of an investigational medication to test if it may reduce symptoms of depression, associated with bipolar I disorder.

Not sure where to start? Check in on your mental health

These are the same validated questionnaires clinicians and researchers use every day. Answer honestly, see your results explained in plain language, and share them with anyone you choose.

Take a free self-assessment
  • Nothing you enter is stored or sent to us
  • Results explained, with clear next steps
  • Every questionnaire and result is a shareable link

Current Studies

Not sure which study fits? A short self-assessment can help you narrow it down.

Check Yourself

Studies now enrolling

Depression · Ascend

We are doing research for a new investigational treatment option to see if it is effective in improving depression. If you suffer from depression, you may be eligible to participate.

This study is sponsored by Definium Therapeutics, formerly MindMed.

PTSD · EMPOWER

The EMPOWER Study is a clinical trial exploring a new oral investigational medication for people experiencing symptoms of post-traumatic stress disorder (PTSD).

This study is sponsored by Transcend Therapeutics, Inc.

Anxiety · RECLAIM

This research study is evaluating a single dose of an investigational psychedelic medication vs. placebo to see if it may help reduce symptoms of generalized anxiety disorder (GAD).

This study is sponsored by Reunion.

Bipolar · Illuminate1

The Illuminate1 Study is evaluating the safety and efficacy of an investigational medication to test if it may reduce symptoms of depression, associated with bipolar I disorder.

This study is sponsored by LB Pharmaceuticals.

New to clinical trials? Start with our beginner's guide

Coming soon

Studies we expect to open in Orem in the coming months. They aren't enrolling yet.

  • PTSD

    Compass Pathways · Redefine

  • Generalized anxiety

    Otsuka

  • PMDD

    MycoMedica

Hear first when one opens

Join the interest list. When a study you pick starts enrolling, our team will reach out to tell you and talk through whether it might be a fit. Joining doesn't sign you up for a study, and you can ask to come off the list any time.

Questions now? Call or text 801-871-5516.

Frequently Asked Questions

Still have a question? Our team is happy to walk you through anything, including whether a study might be a fit.

Call 801-871-5516

Send us a message

Questions and answers

The strength of our science lies in our people

Inner Space Research co-founders Dr. Reid Robison and Dr. Steve Thayer

About Us

Inner Space Research is a psychiatry-focused clinical research center in Orem, Utah, led by experienced clinicians and investigators dedicated to advancing innovative mental health treatments.

With decades of combined experience and leadership across hundreds of clinical trials, including research on ketamine and emerging psychedelic-assisted therapies, our team works at the intersection of rigorous science and compassionate care. Our purpose is to expand safe, evidence-based treatment options and contribute to research that is shaping the future of mental health.

A room at the Inner Space Research office with a sofa, a tree print, a bamboo plant, and a colorful rug The Inner Space Research sign on the office in Orem
Dr. Steve Thayer, CEO. A smiling man with a full beard wearing a blue sweater, against a plain light background.

Steve Thayer, PhD

CEO and Co-founder

Dr. Reid Robison, Chief Medical Officer. A middle-aged man with gray hair and beard in a light blue button-up shirt, against a plain white background.

Reid Robison, MD

Chief Medical Officer and Co-founder

Work with us

We're hiring for research and clinical roles in Orem.

See open roles

Get in Touch

We’re here to help and happy to answer your questions. Reach out anytime.

Fax (385) 582-0110

Send us a message and our team will follow up.

Leave out medical history for now. We'll go over that by phone.

In a crisis, call or text 988, or call 911.

How to find us

560 S State St, Suite D-1
Orem, Utah 84058

  • Look for the green sign. Our door is under the 560, just right of the Inner Space Research sign.
  • Free parking. Heading south on State St, turn right into the lot, drive past the two buildings nearest the street, and park behind them.
  • Visits by appointment. Office hours are Monday–Friday, 9 am–5 pm.
The Inner Space Research building in Orem on a sunny day, with the mountains behind it
The front porch at 560, with the green Inner Space Research sign in the window and the door to its right
One of our dosing rooms, with armchairs, a sofa, plants and soft pendant lights

Generalized Anxiety Disorder: Treatment Options and Clinical Trials in Utah

July 31, 2026

Living with Generalized Anxiety Disorder (GAD) often means more than the occasional bout of worry — it's persistent, hard to control, and can interfere with daily life even when nothing is obviously "wrong." If standard treatments like therapy or medication haven't given you the relief you're looking for, a clinical trial may be worth exploring.

What Is Generalized Anxiety Disorder?

GAD is a chronic anxiety disorder marked by excessive, ongoing worry about a wide range of everyday things — work, health, relationships, finances — that's difficult to control and often out of proportion to the actual situation. It can come with physical symptoms too: muscle tension, restlessness, fatigue, trouble concentrating, and disrupted sleep.

Standard treatment usually involves a combination of therapy (often cognitive behavioral therapy) and medication, such as SSRIs or SNRIs. These approaches help many people, but not everyone finds full relief, and some medications take weeks to have an effect or come with side effects that are hard to tolerate.

Why Consider a Clinical Trial?

Clinical trials test new approaches to treatment under close medical supervision, following a protocol reviewed and approved by an Institutional Review Board (IRB) to protect participants. For anxiety specifically, researchers are exploring treatments that work differently than traditional daily medications — including options designed to work faster or with a different dosing approach altogether.

One example is a study currently enrolling at Inner Space Research, evaluating whether a single dose of an investigational treatment (RE104) can reduce anxiety symptoms in adults with GAD, compared to placebo. This kind of research matters because it could open the door to treatment options that don't require the daily commitment many current medications do.

What Screening Looks Like

If you're interested in participating, the process typically starts with a conversation — either by phone or in person — where a study coordinator asks about your anxiety symptoms, treatment history, and general health. If you seem like a good fit, you'll come in for a more complete evaluation, which may include:

  • A structured interview to confirm a GAD diagnosis and assess symptom severity.
  • A review of current and past medications or therapies you've tried.
  • A basic physical exam and lab work to confirm you're medically eligible.

This process exists to make sure the study is actually a good fit for you — not just to fill enrollment numbers.

What Participating Involves

Once enrolled, you'll follow the visit schedule set out in the study protocol. This generally includes:

  • Regular visits with the study team to monitor how you're doing and check for any side effects.
  • Symptom rating scales completed at set intervals to track your anxiety levels over time.
  • Safety monitoring throughout the study, since participant wellbeing is the top priority.

Depending on the specific trial, you may receive the investigational treatment or a placebo — this comparison is what allows researchers to determine whether the treatment actually works, separate from other factors like time or attention from the care team.

What You Get From Participating

Beyond the potential of symptom relief, participants typically receive study-related care at no cost, along with more frequent check-ins than many people get through routine care. You're also contributing directly to research that could shape future anxiety treatments for others.

Could You Be a Candidate?

If you're an adult in the Orem, Utah area living with Generalized Anxiety Disorder and looking for options beyond what you've already tried, you may qualify for our current GAD study evaluating a single dose of RE104. Reaching out is simply a conversation — there's no obligation, and our team is happy to answer your questions.

This article is for general educational purposes and is not a substitute for medical advice. Please consult your healthcare provider about your specific situation and treatment options.

Now enrolling in Orem

Anxiety study · RECLAIM

This research study is evaluating a single dose of an investigational psychedelic medication vs. placebo to see if it may help reduce symptoms of generalized anxiety disorder (GAD).

More guides

404

This page isn't here

It may have moved when we rebuilt our site, or the link has a typo. These are good places to start.

Looking for a study? Call or text 801-871-5516.

Thanks. We got your message.

Our team will be in touch soon. Want to talk sooner? Call or text 801-871-5516.

Check in on your mental health

These are the same validated questionnaires clinicians and researchers use every day. Answer honestly, see your results explained in plain language, and share them with anyone you choose: a friend, a family member, your doctor, or our team.

Nothing you enter is stored or sent to us
Results explained, with clear next steps
Every questionnaire and result is a shareable link

In crisis? Call or text 988, anytime.

EPDS, 10 questions, about 2 min

Depression in pregnancy & after birth

The Edinburgh Postnatal Depression Scale, the standard screen during pregnancy and the year after birth, when ordinary depression questions about sleep and appetite can mislead. Ten questions about the past seven days.

About the EPDS & how scoring works

HAM-A, 14 questions, about 3 min

Anxiety, including physical symptoms

A self-rating worksheet covering the 14 symptom areas of the Hamilton Anxiety Rating Scale: worry and tension, but also the physical side the GAD-7 never asks about. Fourteen questions about the past week. Not a validated self-report scale.

About the HAM-A & how scoring works

MDQ, 15 questions, about 3 min

Bipolar disorder

The standard screen for lifetime manic or hypomanic symptoms, often used to check whether depression may be part of a bipolar pattern. Fifteen questions.

About the MDQ & how scoring works

ASRS, 6 questions, about 2 min

Adult ADHD

The World Health Organization’s six-question screen for adult ADHD: a quick read on whether attention and restlessness symptoms are currently affecting your life. Six questions about the past six months.

About the ASRS & how scoring works

Y-BOCS-SR, 10 questions, about 4 min

Obsessive-compulsive disorder

The standard clinical measure of obsessive-compulsive symptom severity, adapted for self-report. Ten questions, scored separately for obsessions and compulsions.

About the Y-BOCS-SR & how scoring works

DSM-XC, 23 questions, about 4 min

Overall check across 13 domains

The American Psychiatric Association’s 23-question wide-angle snapshot across 13 mental health domains, a map of what might deserve a closer look. Note: it does not cover trauma or PTSD; use the PCL-5 for that.

About the DSM-XC & how scoring works

Mood & unusual experiences, 12 questions, about 4 min

When mood and unusual experiences both show up

If you have been told “bipolar” by one person and “schizoaffective” by another, the difference comes down to timing: whether unusual experiences ever happened on their own. This walks through that timeline the way a clinician would. Not a scored test, and not a diagnosis.

About this walkthrough & how it reads your answers

How this relates to our studies

Inner Space Research runs clinical trials of investigational treatments for depression, anxiety, PTSD, and other mental health conditions.

A score here doesn't determine whether you qualify for a study. Only a full evaluation with our clinical team can do that. But it can give you (and us) a useful starting point. If your results suggest you might be a fit, we'd love to hear from you.

Private by design

Your answers never leave your device. When you finish a questionnaire, your results are encoded directly into a web link. That link is your result. Share it, bookmark it, or close the page and it's gone. We don't store, transmit, or see anything unless you choose to send your results to someone.

Sending someone here?

Clinicians, friends, and our own prescreening team are welcome to link people directly to any questionnaire. Each questionnaire has its own page you can link to.

In crisis or thinking about suicide?

Call or text 988 (Suicide & Crisis Lifeline, U.S.). Free, confidential, 24/7.

If you're in immediate danger, call 911 or go to your nearest emergency room.

These screeners are offered free to our community. They are educational tools: not a diagnosis, not medical advice, and not a determination of eligibility for any research study. No answers are stored or transmitted by this site; your results live only in your browser and in the link you choose to keep or share.

Sources. PHQ-9 and GAD-7: developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke and colleagues, with an educational grant from Pfizer Inc.; no permission required to reproduce. PCL-5: Weathers, Litz, Keane, Palmieri, Marx, & Schnurr (2013), U.S. National Center for PTSD; public domain. EPDS: Cox, J.L., Holden, J.M., & Sagovsky, R. (1987). Detection of postnatal depression: Development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry, 150, 782–786. MDQ: © 2000 by The University of Texas Medical Branch, reprinted with permission. ASRS v1.1 Screener: © World Health Organization; Kessler et al. (2005). Y-BOCS: adapted for self-report from Goodman et al. (1989), Archives of General Psychiatry, 46, 1006–1011. HAM-A worksheet: a plain-language self-rating adaptation of Hamilton (1959), British Journal of Medical Psychology, 32, 50–55; not a validated self-report scale. DSM-5 Level 1 Cross-Cutting Symptom Measure: © 2013 American Psychiatric Association; this material can be reproduced without permission by researchers and by clinicians for use with their patients. The mood and unusual experiences walkthrough was written by Inner Space Research and is not a scored instrument.

Stay in the Loop

Sign up for updates on new studies, podcast drops, events and more.

We respect your privacy.